Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland.
Clin J Am Soc Nephrol. 2012 Nov;7(11):1843-51. doi: 10.2215/CJN.02200312. Epub 2012 Aug 16.
The complement cascade seems to be an important mediator modulating renal ischemia/reperfusion injury. This study analyzed whether significant changes occur in the levels of a terminal panel of complement molecules (C3a, C5a, and C5b-9/membrane attack complex) during the early phase of human kidney allograft reperfusion and evaluated the potential association of these changes with clinical post-transplant graft function in kidney transplant recipients.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Seventy-five renal transplant recipients undergoing transplantation between 2004 and 2006 were enrolled in the study and divided into early, slow, and delayed graft function groups. Blood samples were collected perioperatively during consecutive minutes of allograft reperfusion from the renal vein. Levels of complement molecules were measured using ELISA.
Analysis revealed no significant changes in C3a and C5a levels throughout reperfusion. The main complement molecule that was significantly associated with post-transplant graft function was C5b-9/membrane attack complex; throughout the reperfusion period, perioperative levels of C5b-9/membrane attack complex were around two to three times higher in delayed graft function patients than early and slow graft function individuals (P<0.005). In addition, C5b-9/membrane attack complex levels had a relatively high clinical sensitivity and specificity (70%-87.5%) for the prediction of early and long-term (1 year) post-transplant allograft function.
This clinical study supports a role for the complement cascade in delayed graft function development. However, additional studies are needed to elucidate the exact mechanisms responsible for this phenomenon. In addition, perioperative measurements of C5b-9/membrane attack complex are highlighted as promising potential clinical markers of post-transplant renal allograft function.
补体级联反应似乎是调节肾缺血/再灌注损伤的重要介质。本研究分析了在人肾移植再灌注的早期阶段,补体终末分子(C3a、C5a 和 C5b-9/膜攻击复合物)的水平是否会发生显著变化,并评估了这些变化与移植后肾功能的潜在相关性。
设计、设置、参与者和测量:本研究纳入了 2004 年至 2006 年间接受移植的 75 例肾移植受者,并将其分为早期、缓慢和延迟肾功能组。在连续分钟的移植肾再灌注过程中,从肾静脉采集手术期间的血液样本。使用 ELISA 测量补体分子的水平。
分析显示,在再灌注过程中 C3a 和 C5a 水平没有明显变化。与移植后移植物功能显著相关的主要补体分子是 C5b-9/膜攻击复合物;在整个再灌注期间,延迟肾功能患者的 C5b-9/膜攻击复合物的围手术期水平比早期和缓慢肾功能患者高 2 至 3 倍(P<0.005)。此外,C5b-9/膜攻击复合物水平对早期和长期(1 年)移植后移植物功能的预测具有较高的临床灵敏度和特异性(70%-87.5%)。
这项临床研究支持补体级联反应在延迟肾功能发展中的作用。然而,需要进一步的研究来阐明导致这种现象的确切机制。此外,C5b-9/膜攻击复合物的围手术期测量被强调为移植后肾移植功能的有前途的潜在临床标志物。